Chief Medical Officer
T1D Exchange
Boston, Massachusetts
He is Chief Medical Officer at T1D Exchange. Dr. Ebekozien leads the T1D Exchange Quality Improvement network of over 60 U.S. diabetes centers. His work focuses on diabetes health equity and quality improvement to improve real-world outcomes. He received the 2022 Eli Lilly Research and 2021 ISPAD Innovation Awards.
Disclosure information not submitted.
F29 - Reduce Inequities In Diabetes Outcomes in Ten Practical Steps
Friday, August 9, 2024
4:45 PM – 5:30 PM CT